- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-octamer
- Ligands
- 16 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)(Covalent)
ATP.3: 13 residues within 4Å:- Chain A: S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213
- Chain F: R.166
- Ligands: GTP.1, ATP.28
11 PLIP interactions:9 interactions with chain A, 2 interactions with chain F- Hydrogen bonds: A:S.164, A:S.165, A:R.166, A:D.167, A:T.185, A:V.191, A:V.191, F:R.166
- Salt bridges: A:R.166, A:R.166, F:R.166
ATP.8: 13 residues within 4Å:- Chain B: S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213
- Chain E: R.166
- Ligands: GTP.6, ATP.23
13 PLIP interactions:11 interactions with chain B, 2 interactions with chain E- Hydrogen bonds: B:S.164, B:S.165, B:R.166, B:D.167, B:D.167, B:T.185, B:V.191, B:V.191
- Salt bridges: B:R.166, B:R.166, B:R.166, E:R.166, E:R.166
ATP.13: 13 residues within 4Å:- Chain C: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213
- Chain H: R.166
- Ligands: GTP.11
13 PLIP interactions:12 interactions with chain C, 1 interactions with chain H- Hydrogen bonds: C:S.164, C:S.164, C:S.165, C:R.166, C:D.167, C:D.167, C:T.185, C:V.191, C:V.191, C:K.211
- Salt bridges: C:R.166, C:R.166, H:R.166
ATP.18: 13 residues within 4Å:- Chain D: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213
- Chain G: R.166
- Ligands: GTP.16
13 PLIP interactions:10 interactions with chain D, 3 interactions with chain G- Hydrogen bonds: D:S.164, D:R.166, D:D.167, D:D.167, D:D.169, D:T.185, D:V.191, D:V.191
- Salt bridges: D:R.166, D:R.166, G:R.166, G:R.166, G:K.233
ATP.23: 12 residues within 4Å:- Chain B: R.166
- Chain E: S.164, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213
- Ligands: ATP.8, GTP.21
14 PLIP interactions:11 interactions with chain E, 3 interactions with chain B- Hydrogen bonds: E:S.164, E:R.166, E:D.167, E:D.167, E:T.185, E:V.191, E:V.191, E:K.211
- Salt bridges: E:R.166, E:R.166, E:K.213, B:R.166, B:R.166, B:R.166
ATP.28: 14 residues within 4Å:- Chain A: R.166
- Chain F: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213
- Ligands: ATP.3, GTP.26
14 PLIP interactions:12 interactions with chain F, 2 interactions with chain A- Hydrogen bonds: F:S.164, F:S.164, F:S.164, F:S.165, F:D.167, F:T.185, F:V.191, F:V.191
- Salt bridges: F:R.166, F:R.166, F:R.166, F:K.213, A:R.166, A:R.166
ATP.33: 14 residues within 4Å:- Chain D: R.166, K.233
- Chain G: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213
- Ligands: GTP.31
11 PLIP interactions:3 interactions with chain D, 8 interactions with chain G- Salt bridges: D:R.166, D:R.166, D:K.233, G:R.166, G:R.166
- Hydrogen bonds: G:S.164, G:D.167, G:D.167, G:T.185, G:V.191, G:K.213
ATP.38: 14 residues within 4Å:- Chain C: R.166, K.210, K.233
- Chain H: I.162, S.164, S.165, R.166, D.167, T.185, L.190, V.191, K.211, G.212, K.213
12 PLIP interactions:9 interactions with chain H, 3 interactions with chain C- Hydrogen bonds: H:S.164, H:D.167, H:T.185, H:V.191, H:V.191
- Salt bridges: H:R.166, H:R.166, H:R.166, H:K.213, C:R.166, C:R.166, C:K.233
- 8 x IMP: INOSINIC ACID(Covalent)
IMP.4: 21 residues within 4Å:- Chain A: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.5
14 PLIP interactions:14 interactions with chain A- Hydrogen bonds: A:S.73, A:N.308, A:R.327, A:R.327, A:S.334, A:S.334, A:G.371, A:I.372, A:G.392, A:S.393, A:M.419, A:G.420, A:S.421, A:Q.446
IMP.9: 22 residues within 4Å:- Chain B: S.73, M.75, N.308, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.10
12 PLIP interactions:12 interactions with chain B- Hydrogen bonds: B:N.308, B:R.327, B:R.327, B:S.334, B:G.371, B:I.372, B:G.392, B:S.393, B:M.419, B:G.420, B:S.421, B:Q.446
IMP.14: 22 residues within 4Å:- Chain C: S.73, M.75, N.308, R.327, G.333, S.334, I.335, C.336, T.338, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.15
13 PLIP interactions:13 interactions with chain C- Hydrogen bonds: C:S.73, C:S.73, C:N.308, C:R.327, C:R.327, C:S.334, C:G.371, C:I.372, C:G.392, C:S.393, C:M.419, C:G.420, C:Q.446
IMP.19: 23 residues within 4Å:- Chain D: S.73, M.75, N.308, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, M.391, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.20
13 PLIP interactions:13 interactions with chain D- Hydrogen bonds: D:S.73, D:N.308, D:R.327, D:R.327, D:S.334, D:G.370, D:G.371, D:G.392, D:S.393, D:M.419, D:G.420, D:S.421, D:Q.446
IMP.24: 21 residues within 4Å:- Chain E: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.25
13 PLIP interactions:13 interactions with chain E- Hydrogen bonds: E:S.73, E:N.308, E:R.327, E:R.327, E:S.334, E:G.371, E:G.392, E:S.393, E:Y.416, E:M.419, E:G.420, E:S.421, E:Q.446
IMP.29: 22 residues within 4Å:- Chain F: S.73, M.75, N.308, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, S.421, Q.446, G.447
- Ligands: NAD.30
14 PLIP interactions:14 interactions with chain F- Hydrogen bonds: F:S.73, F:N.308, F:R.327, F:R.327, F:S.334, F:D.369, F:G.371, F:G.392, F:S.393, F:Y.416, F:M.419, F:G.420, F:S.421, F:Q.446
IMP.34: 21 residues within 4Å:- Chain G: S.73, M.75, N.308, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.35
14 PLIP interactions:14 interactions with chain G- Hydrogen bonds: G:S.73, G:N.308, G:R.327, G:R.327, G:S.334, G:D.369, G:G.370, G:G.371, G:G.392, G:S.393, G:Y.416, G:M.419, G:G.420, G:Q.446
IMP.39: 20 residues within 4Å:- Chain H: S.73, M.75, R.327, G.333, S.334, I.335, C.336, D.369, G.370, G.371, M.390, G.392, S.393, Y.416, G.418, M.419, G.420, Q.446, G.447
- Ligands: NAD.40
13 PLIP interactions:13 interactions with chain H- Hydrogen bonds: H:S.73, H:R.327, H:R.327, H:S.334, H:D.369, H:G.371, H:G.392, H:S.393, H:Y.416, H:M.419, H:G.420, H:S.421, H:Q.446
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
NAD.5: 15 residues within 4Å:- Chain A: T.257, H.258, D.279, S.280, S.281, F.287, G.329, M.330, C.336, T.338, M.419, G.420, Q.446
- Chain D: Q.474
- Ligands: IMP.4
11 PLIP interactions:9 interactions with chain A, 2 interactions with chain D- Hydrophobic interactions: A:Q.446
- Hydrogen bonds: A:T.257, A:T.257, A:D.279, A:S.281, A:G.329, A:Q.446, D:Q.474, D:Q.474
- pi-Stacking: A:H.258, A:F.287
NAD.10: 17 residues within 4Å:- Chain A: Q.474
- Chain B: T.257, H.258, D.279, S.280, S.281, F.287, N.308, G.329, M.330, G.331, C.336, T.338, M.419, G.420, Q.446
- Ligands: IMP.9
13 PLIP interactions:2 interactions with chain A, 11 interactions with chain B- Hydrogen bonds: A:Q.474, A:Q.474, B:T.257, B:T.257, B:E.259, B:D.279, B:S.281, B:G.331
- Hydrophobic interactions: B:Q.446
- Salt bridges: B:H.258
- pi-Stacking: B:H.258, B:F.287, B:F.287
NAD.15: 15 residues within 4Å:- Chain B: Q.474
- Chain C: T.257, H.258, E.259, D.279, S.280, S.281, F.287, G.329, M.330, T.338, M.419, G.420, Q.446
- Ligands: IMP.14
14 PLIP interactions:12 interactions with chain C, 2 interactions with chain B- Hydrophobic interactions: C:Q.446
- Hydrogen bonds: C:T.257, C:T.257, C:E.259, C:D.279, C:S.281, C:G.329, C:Q.446, B:Q.474, B:Q.474
- Salt bridges: C:H.258
- pi-Stacking: C:H.258, C:F.287, C:F.287
NAD.20: 15 residues within 4Å:- Chain C: Q.474
- Chain D: T.257, H.258, D.279, S.280, S.281, F.287, G.329, M.330, C.336, T.338, M.419, G.420, Q.446
- Ligands: IMP.19
13 PLIP interactions:11 interactions with chain D, 2 interactions with chain C- Hydrophobic interactions: D:Q.446
- Hydrogen bonds: D:T.257, D:T.257, D:D.279, D:S.281, D:G.329, D:Q.446, C:Q.474, C:Q.474
- Salt bridges: D:H.258
- pi-Stacking: D:H.258, D:F.287, D:F.287
NAD.25: 16 residues within 4Å:- Chain E: T.257, H.258, D.279, S.280, S.281, F.287, N.308, G.329, M.330, C.336, T.338, M.419, G.420, Q.446
- Chain H: Q.474
- Ligands: IMP.24
13 PLIP interactions:11 interactions with chain E, 2 interactions with chain H- Hydrophobic interactions: E:Q.446
- Hydrogen bonds: E:T.257, E:H.258, E:D.279, E:S.281, E:G.329, E:G.331, E:Q.446, H:Q.474, H:Q.474
- pi-Stacking: E:H.258, E:F.287, E:F.287
NAD.30: 16 residues within 4Å:- Chain E: Q.474
- Chain F: T.257, H.258, D.279, S.280, S.281, F.287, N.308, G.329, M.330, C.336, T.338, M.419, G.420, Q.446
- Ligands: IMP.29
12 PLIP interactions:10 interactions with chain F, 2 interactions with chain E- Hydrophobic interactions: F:Q.446
- Hydrogen bonds: F:T.257, F:D.279, F:S.281, F:G.329, F:Q.446, E:Q.474, E:Q.474
- Salt bridges: F:H.258
- pi-Stacking: F:H.258, F:F.287, F:F.287
NAD.35: 16 residues within 4Å:- Chain F: Q.474
- Chain G: T.257, H.258, D.279, S.280, S.281, F.287, N.308, G.329, M.330, C.336, T.338, M.419, G.420, Q.446
- Ligands: IMP.34
12 PLIP interactions:10 interactions with chain G, 2 interactions with chain F- Hydrophobic interactions: G:Q.446
- Hydrogen bonds: G:T.257, G:D.279, G:S.281, G:G.329, G:Q.446, F:Q.474, F:Q.474
- Salt bridges: G:H.258
- pi-Stacking: G:H.258, G:F.287, G:F.287
NAD.40: 13 residues within 4Å:- Chain G: Q.474
- Chain H: T.257, H.258, D.279, S.280, S.281, F.287, G.331, C.336, T.338, M.419, G.420
- Ligands: IMP.39
12 PLIP interactions:10 interactions with chain H, 2 interactions with chain G- Hydrogen bonds: H:T.257, H:S.281, H:G.331, H:T.338, H:T.338, H:Q.446, G:Q.474, G:Q.474
- Salt bridges: H:H.258
- pi-Stacking: H:H.258, H:F.287, H:F.287
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- O'Neill, A.G. et al., Neurodevelopmental disorder mutations in the purine biosynthetic enzyme IMPDH2 disrupt its allosteric regulation. J.Biol.Chem. (2023)
- Release Date
- 2023-04-19
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-octamer
- Ligands
- 16 x GTP: GUANOSINE-5'-TRIPHOSPHATE(Non-covalent)
- 8 x ATP: ADENOSINE-5'-TRIPHOSPHATE(Non-covalent)(Covalent)
- 8 x IMP: INOSINIC ACID(Covalent)
- 8 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- O'Neill, A.G. et al., Neurodevelopmental disorder mutations in the purine biosynthetic enzyme IMPDH2 disrupt its allosteric regulation. J.Biol.Chem. (2023)
- Release Date
- 2023-04-19
- Peptides
- Inosine-5'-monophosphate dehydrogenase 2: ABCDEFGH
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
BC
CD
DE
EF
FG
GH
H